Clinical trials
Bowel Disease clinical trials
Below are recruiting bowel disease clinical trials, each written for real people, not researchers. We’re tracking 283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02193464Recruiting
Local registry study for Crohn’s and ulcerative colitis
This study keeps a health record (a registry) of people in Daegu-Gyeongbuk with Crohn’s disease or ulcerative colitis. It helps researchers understand the illnesses in this region and improve future care planning.
DaeguAges Any age - NCT04946448Recruiting
Test a Crohn’s diet and biologic medicine combination
This study tests whether combining a specific diet with biologic medicines can reduce active inflammation and symptoms of Crohn’s disease. It may help people who still have active disease in the bowel despite prior care.
LeuvenAges 18–80 - NCT06683105Recruiting
App for IBD patients to manage their own diet
This study tests a mobile app called MYIBDDiet that helps people with inflammatory bowel disease (IBD) manage their own diet. You might be able to join if you have IBD but are not in a flare, not on a special diet already, and don't have other conditions that require a special diet.
Edmonton, AlbertaAges 18 years+ - NCT04806620Recruiting
Online app study for brain inflammation lifestyle data
This study uses a digital platform (app/website) to collect lifestyle and symptom information to better understand brain inflammation. You may qualify if you have certain conditions like Long COVID, migraines, autoimmune disease, inflammatory gut issues, mood disorders, or if you are a healthy comparison person.
Delafield, WisconsinAges 2 years+ - NCT06971627Recruiting
Remote monitoring for inflammatory bowel disease
This trial tests if regular video check-ins via phone or computer can help people with IBD stick to their medications and feel better emotionally. You would use a messaging app and video calls to stay in touch with your care team from home.
IstanbulAges 18 years+ - NCT06721767Recruiting
IBD monitoring study at a regional center
This trial is a monitoring study for people with inflammatory bowel diseases (IBD), such as Crohn's disease or ulcerative colitis. It aims to follow patients who have been seen at a specialized IBD center to gather information and improve care.
BolognaAges 14 years+ - NCT07335705Recruiting
Factors affecting bowel prep in IBD patients
This study looks at factors that affect how well the bowel is cleaned before a colonoscopy in people with IBD. The goal is to improve preparation so the colonoscopy can be more effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05428345Recruiting
Shot of vedolizumab skin injection for active bowel inflammation
This study tests whether a weekly/regular skin injection version of vedolizumab can help adults with moderate to severe ulcerative colitis or Crohn’s disease who did not fully respond to other treatments or TNF blockers. It may help by moving you from an intravenous (IV) infusion to a self/clinic injection option.
Goyang-si, Gyeonggi-doAges 18 years+ - NCT05332639Recruiting
Risk tracking test for Crohn’s disease in teens
This study checks whether a personalized tool can estimate someone’s risk for Crohn’s disease before symptoms start. It may help families learn early risk and decide on next steps sooner.
Boston, MassachusettsAges 14 years+ - NCT06553053Recruiting
Acupuncture to prevent Crohn's disease relapse
This trial tests if acupuncture can help people with Crohn's disease stay in remission longer and avoid flare-ups. If you are in remission but have had frequent relapses, this study may be for you.
ShanghaiAges 16–75 - NCT03917303RecruitingPhase 4
Check-in app for people with newly diagnosed Crohn’s disease
This Phase 4 study tests whether using the myIBDcoach smartphone app helps people with Crohn’s disease manage their care. It’s for people who are newly diagnosed or having a flare and have not used biologic medicines before.
MaastrichtAges 18–70 - NCT04960826Recruiting
Study of an environmental risk factor in Crohn’s
This study looks at how an environmental factor may be linked to Crohn’s disease, especially around the time you need certain bowel surgery. Your experience may help researchers understand risk and how it relates to your gut health.
LilleAges 25–60 - NCT06351124RecruitingPhase 1/Phase 2
Beta-hydroxybutyrate for active Crohn's disease when starting new therapy
This study tests whether a natural substance called beta-hydroxybutyrate (BHB) can help treat active Crohn's disease when you start a new prescription therapy. It aims to see if adding BHB is safe and practical.
Austin, TexasAges 18 years+ - NCT06604728Recruiting
IV vs. shot biologics for IBD: which works better?
This study compares intravenous (IV) and under-the-skin (subcutaneous) biologic drugs for people with Crohn's disease or ulcerative colitis. It helps doctors understand if switching from the IV form to a shot is as effective and well-tolerated.
RomaAges 18 years+ - NCT06754891RecruitingPhase 1
A study of TQH3906 for moderate to severe inflammatory bowel disease
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
Bengbu, AnhuiAges 18–75 - NCT07033208Recruiting
Testing a wireless thermal capsule for the digestive tract
This study tests a new wireless capsule that you swallow, like a pill, to measure temperature inside your digestive tract. It is for healthy volunteers to see if the device is safe and works well.
Boston, MassachusettsAges 18–75 - NCT07219537Recruiting
Imaging the lower gut with a new capsule
This trial tests a new type of camera capsule that takes pictures of the lower part of your digestive tract. It may be an option for people who are healthy or have Lynch Syndrome and have had a recent normal colonoscopy.
Boston, MassachusettsAges 18–75 - NCT04844606RecruitingPhase 3
Mirikizumab for kids with ulcerative colitis or Crohn’s
This study checks whether continuing mirikizumab (a medicine that calms gut inflammation) helps children with ulcerative colitis or Crohn’s disease after prior study treatment. It aims to see if staying on the medicine is beneficial and safe over time.
San Francisco, CaliforniaAges 2–19 - NCT06793124Recruiting
Comparing tests for CMV in bowel disease patients
This trial compares different diagnostic tests to find the best way to detect cytomegalovirus (CMV) organ disease in people with inflammatory bowel disease (IBD) whose symptoms get worse and need hospital care. The goal is to improve diagnosis and treatment for this complication.
Bologna, BolognaAges 18 years+ - NCT06001450Recruiting
Plastics and toxins in pregnant women and families
This study looks at how plastics and toxins in the environment might affect inflammation in the gut, especially in pregnant women with Crohn's disease and their families. It will help doctors understand if these chemicals play a role in bowel inflammation during pregnancy.
New York, New YorkAges 18 years+ - NCT03571373Recruiting
Study of new childhood IBD and tracking safety
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
RotterdamAges birth–19 years - NCT05704413Recruiting
Biobank study using gut tissue in bowel disease
This study collects and stores digestive (bowel) tissue to better understand how gut bacteria may affect diseases like ulcerative colitis or Crohn’s disease. It may help researchers find future ways to improve care for people with these conditions.
ParisAges 18 years+ - NCT06453720Recruiting
Predicting Crohn's treatment success with gut bacteria
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
Vancouver, British ColumbiaAges 19–80 - NCT06550310Recruiting
Nutrition and IBD treatment outcomes
This study looks at how nutrition affects people with IBD who are starting a new treatment or having surgery. Researchers want to find out if diet or body changes influence how well you recover.
LondonAges 16 years+
Hear when a new Bowel Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bowel disease?
- Yes. Clin2 currently lists 283 recruiting bowel disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bowel disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bowel disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.